Screener
PPC
Propanc Biopharma
PPCBPropanc Biopharma is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO James Nathanielsz, with a market cap of $2.7M.
$2.73M-88.9%
We’re still putting together Propanc Biopharma’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.
Ask us to move Propanc Biopharma up the queue, and we’ll analyze its filings next.
Earnings
Next report
Date not yet announcedProfile
CountryAustralia
Listed2012
CEOJames Nathanielsz
SectorHealthcare
IndustryBiotechnology
Websitepropanc.com
FilingsSEC EDGAR